The second edition of X Axis looks at how scientific infrastructure is keeping pace with the science within it. From designing laboratories for research directions that don’t yet exist, to why life sciences companies are choosing bigger spaces and longer leases, this edition examines the decisions shaping R&D real estate today. It also explores why chemistry companies outgrow conventional facilities faster than they expect.
The edition opens with a note from our CEO & Managing Director, Ashish Singh, on India’s R&D spending and the infrastructure needed to support the country’s growth in science and innovation. Alongside, we take a closer look at Genome Valley, India’s first organised life sciences cluster for R&D and manufacturing, and 12GV, a USD 100 million investment creating over one million square feet of life sciences infrastructure within it. Download the newsletter to know more.
